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Hematopoietic stem cells (HSCs) are main-
tained in an undifferentiated quiescent state
within a bone marrow niche. Here we show
that Foxo3a, a forkhead transcription factor
that acts downstream of the PTEN/PI3K/Akt
pathway, is critical for HSC self-renewal. We
generated gene-targeted Foxo3a/ mice and
showed that, although the proliferation and
differentiation of Foxo3a/ hematopoietic pro-
genitors were normal, the number of colony-
forming cells present in long-term cocultures
of Foxo3a/ bone marrow cells and stromal
cells was reduced. The ability of Foxo3a/
HSCs to support long-term reconstitution of
hematopoiesis in a competitive transplantation
assay was also impaired. Foxo3a/ HSCs
also showed increased phosphorylation of
p38MAPK, an elevation of ROS, defective main-
tenance of quiescence, and heightened sen-
sitivity to cell-cycle-specific myelotoxic injury.
Finally, HSC frequencies were significantly
decreased in aged Foxo3a/ mice compared
to the littermate controls. Our results demon-
strate that Foxo3a plays a pivotal role in main-
taining the HSC pool.INTRODUCTION
FOXO transcription factors belong to the forkhead family
of transcriptional regulators that is characterized by a con-
served DNA binding domain termed the ‘‘forkhead box’’
(Kaestner et al., 2000). The FOXO group of human fork-
head proteins contains four members: FOXO1, FOXO3a,
FOXO4, and FOXO6. FOXO proteins are normally present
in an active state in a cell’s nucleus. In response to the
binding of growth factors or insulin to the appropriate
cell surface receptors, the activation of phosphatidylino-
sitol 3-kinase (PI3K) is triggered. PI3K in turn activates
several serine/threonine kinases, including protein kinase
B (PKB/Akt) and the related SGK family enzymes (Brunet
et al., 1999, 2001; Kops et al., 1999). Activated Akt phos-
phorylates FOXO proteins at three consensus Akt phos-
phorylation sites, triggering the inactivation of these
molecules and their export from the nucleus into the
cytoplasm.
FOXO proteins have both distinct and overlapping
functions, and their many target molecules are involved
in processes as diverse as cell-cycle arrest (Dijkers
et al., 2000a; Furukawa-Hibi et al., 2002; Medema et al.,
2000), DNA repair (Furukawa-Hibi et al., 2002; Tran
et al., 2002), cellular differentiation (Nakae et al., 2003),
and cell death (Brunet et al., 1999; Dijkers et al., 2002;
Kaestner et al., 2000). Activation of FOXO proteins occurs
in cultured cells subjected to oxidative stress (Brunet
et al., 2004; Essers et al., 2004; Furukawa-Hibi et al.,Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc. 101
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gans, FOXO proteins are involved in regulating metabo-
lism, stress resistance, and longevity (Greer and Brunet,
2005). However, it has yet to be clarified whether FOXO
proteins modulate longevity and stress responses in ani-
mals. Several mouse models designed to elucidate the
physiological functions of the mammalian Foxo genes
have been reported. Foxo1/ mice die at embryonic
day 10.5 (E10.5) due to defective angiogenesis (Furuyama
et al., 2004; Hosaka et al., 2004). The principal phenotype
of Foxo3a/ mice is an age-dependent female infertility
caused by premature activation of the ovarian follicles
(Castrillon et al., 2003). Foxo3a/ mice also display
hyperproliferation of helper T cells, in line with Foxo3a’s
known role in promoting cell-cycle arrest (Lin et al.,
2004). Foxo4/ mice are viable and do not have an overt
phenotype (Hosaka et al., 2004). Foxo6/ mice have yet
to be reported.
Mammalian hematopoietic stem cells (HSCs) are main-
tained in an undifferentiated quiescent state in a bone
marrow niche (Arai et al., 2004). It is thought that the
mechanisms protecting quiescent HSCs against stress
may contribute to the maintenance of the self-renewal ca-
pacity and life span of HSCs. We have previously demon-
strated that the self-renewal capacity of HSCs depends
on Atm-mediated inhibition of oxidative stress (Ito et al.,
2004). In the presence of reactive oxygen species (ROS),
the p38MAPK pathway is activated such that the HSC
population is exhausted. Prolonged treatment of HSCs
with an antioxidant or a p38MAPK inhibitor can extend
the life span of these cells during serial transplantation, in-
dicating that p38MAPK inactivation protects HSCs
against loss of self-renewal capacity (Ito et al., 2006).
Thus, it seems that genes or factors related to cellular
senescence are involved in regulating the self-renewal
capacity of HSCs.
In this study, we demonstrate that Foxo3a is an impor-
tant contributor to the maintenance of the HSC pool dur-
ing aging. Our findings have implications for the roles of
FOXO proteins in maintenance of tissue homeostasis.
RESULTS
Normal Proliferation, Differentiation, and Apoptosis
of Hematopoietic Progenitors in Foxo3a/ Mice
We generated Foxo3a/ mice by disrupting exon 2 of
the Foxo3a gene with a neo cassette (see Figure S1 in
the Supplemental Data available with this article online
at http://www.cellstemcell.com/content/full/1/1/101/DC1/).
Consistent with a previous report (Castrillon et al., 2003),
our Foxo3a/ mice were viable, and female mice showed
infertility. To investigate the effect of Foxo3a loss on
hematopoiesis, we analyzed the peripheral blood of 8-
week-old Foxo3a+/+ and Foxo3a/ mice. In the latter,
we found a decreased number of red blood cells but a sig-
nificant increase in reticulocytes accompanied by eleva-
tions in the mean corpuscular volume (MCV) and mean
corpuscular hemoglobin (MCH) (Table 1). These findings
indicate that erythropoiesis is abnormal in the absence102 Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc.of Foxo3a, as previously reported (Bakker et al., 2004).
However, numbers of white blood cells and platelets
were comparable in our Foxo3a+/+ and Foxo3a/ mice.
In addition, lymphoid and myeloid cells in Foxo3a/ pe-
ripheral blood and bone marrow (BM) showed wild-type
morphology as determined by May Grunwald-Giemsa
staining (data not shown). Moreover, flow cytometric anal-
yses of T cell (CD3+), B cell (B220+), and myeloid (Mac-1/
Gr-1+) cell populations in Foxo3a/ BM showed that
these cells were present at wild-type frequencies (Fig-
ure S2). These data indicate that the differentiation of all
hematopoietic cells save the erythroid lineage is normal
in Foxo3a/ mice.
Next, we investigated the quality and quantity of hema-
topoietic progenitors in 8- to 12-week-old Foxo3a/
mice. To evaluate the clonogenic capacity and differentia-
tion potential of myeloid and erythroid progenitors, we
performed colony-forming assays in vitro in which freshly
isolated BM mononuclear cells (MNCs) were cultured for
7 days in methylcellulose medium supplemented with
stem cell factor (SCF), thrombopoietin (TPO), erythro-
poietin (Epo), and granulocyte colony stimulating factor
(G-CSF). The numbers and sizes of myeloid (colony-form-
ing unit granulocytes/macrophage, CFU-GM), erythroid
(burst-forming unit-erythroid, BFU-E), and mixed (CFU-
mix) colonies derived from Foxo3a+/+ and Foxo3a/ BM
MNCs were comparable (Figure 1A). The capacity of
Foxo3a/ BM cells to form colonies in the spleen
12 days after transplantation (CFU-S12; short-term repo-
pulating cells) was also equivalent to that of Foxo3a+/+ BM
MNCs (Figure 1B). Foxo3a+/+ and Foxo3a/ BM also con-
tained similar frequencies of c-Kit+Sca-1+Lineage (KSL)
cells, which represent a primitive hematopoietic cell frac-
tion containing HSCs and early progenitors (Figure 1C).
Furthermore, Foxo3a+/+ and Foxo3a/ KSL cells demon-
strated comparable proliferation and differentiation po-
tential in colony-forming assays (Figure 1D). Because it
had been reported that the activation of FOXO by cytokine
Table 1. Blood Cell Counts in 8-Week-Old Foxo3a+/+
and Foxo3a/ Mice
Foxo3a+/+ Foxo3a/ P Value
WBC (ml) 11,000 ± 4,700 13,000 ± 3,100 NS
RBC (3104/ml) 884 ± 79 780 ± 70 <0.01
Hb (g/dl) 13.9 ± 1.0 14.0 ± 1.0 NS
HCT (%) 44.9 ± 2.5 44.7 ± 2.4 NS
MCV (fl) 51.0 ± 2.5 57.5 ± 3.2 <0.01
MCH (pg) 15.8 ± 0.8 18.0 ± 1.0 <0.01
PLT (3104/ml) 85.2 ± 12.4 81.0 ± 15.9 NS
Ret (&) 7.5 ± 0.5 57.5 ± 0.5 <0.01
Values shown are the mean ± SD for 20 mice per genotype.
WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin;
HCT, hematocrit; MCV, mean corpuscular volume; MCH,
mean corpuscular hemoglobin; PLT, platelet; Ret, reticulo-
cyte; NS, not significant.
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(A) Wild-type in vitro colony formation capacity of Foxo3a/ BM MNCs. BM MNCs from Foxo3a+/+ and Foxo3a/ mice were cultured with cytokines
in methylcellulose medium for 7 days. Data shown are the mean number ± SD of colonies for myeloid (CFU-GM, n = 3), erythroid (BFU-E, n = 3), and
mixed (CFU-mix, n = 3) lineages.
(B) Wild-type spleen colony formation by Foxo3a/ BM MNCs. Irradiated mice were transplanted with 5 3 104 BM MNCs from Foxo3a+/+ or
Foxo3a/ mice, and spleen colonies were counted on day 12 posttransplant (CFU-S12). Data shown are the mean number ± SD of colonies (n = 5).
(C) Wild-type frequency of KSL cells in the BM of 8-week-old Foxo3a/ mice. c-Kit+Sca-1+ cells in the Lin fraction (KSL cells) were detected by flow
cytometry. Data shown are a representative pattern of KSL cells. (Insets) Mean percentage ± SD of KSL cells (n = 8).
(D) Wild-type in vitro colony formation capacity of Foxo3a/ KSL cells. KSL cells from Foxo3a+/+ or Foxo3a/ mice were cultured with cytokines in
methylcellulose medium for 7 days. Data shown are the mean number ± SD of colonies (n = 3).
(E) Wild-type apoptosis following cytokine depletion. Lin cells from Foxo3a+/+ and Foxo3a/ mice were cultured without cytokines in serum-
supplemented medium for the indicated times and stained with Annexin V. Data shown are the mean percentage ± SD of Annexin V+ cells. No sig-
nificant differences were observed between Foxo3a+/+ and Foxo3a/ mice (n = 3).depletion leads to cell death in hematopoietic cell lines
(Dijkers et al., 2000a, 2000b, 2002), we evaluated the
apoptosis of immature BM cells (Lineage cells; Lin) cul-
tured in the absence of cytokines. However, Foxo3a+/+
and Foxo3a/ Lin cells did not differ in their kinetics of
apoptosis (Figure 1E). These results indicate that loss of
Foxo3a does not affect the proliferation or differentiation
potential of hematopoietic progenitors in the BM of
healthy mice.
Abrogated Self-Renewal Capacity of HSCs
in the Absence of Foxo3a
To determine if Foxo3a was required for the functions of
primitive hematopoietic cells, we carried out long-term
cultivation of KSL cells on a layer of OP9 stromal cells.In this assay, the number of colony-forming cells arising
after 6 weeks of culture reflects HSC function. The number
of colonies derived from Foxo3a/ KSL cells was sig-
nificantly decreased compared to that derived from
Foxo3a+/+ KSL cells, although short-term cultures (less
than 2 weeks) did not show a significant difference (Fig-
ure 2A). Thus, the most primitive hematopoietic cells in
the BM are profoundly affected by the loss of Foxo3a.
To assess the repopulating capacity of Foxo3a/
HSCs in vivo, we performed a competitive reconstitution
assay in which 4 3 105 BM MNCs from a Foxo3a+/+ or
Foxo3a/ mouse (CD45.2) competed against an equal
number of BM MNCs from a congenic (CD45.1) mouse
to reconstitute the hematopoietic compartment of an
irradiated recipient mouse (CD45.1). At 16 weeksCell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc. 103
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(A) Decreased colony formation after long-term culture. Foxo3a+/+ and Foxo3a/ KSL cells (2 3 103) were cultured on OP9 stromal cells for the
indicated number of weeks (W) and tested for colony formation. Data shown are the mean number ± SD of colonies formed (*p < 0.01, n = 3).
(B) Comparable hematopoietic reconstitution capacity of Foxo3a+/+ and Foxo3a/ BM MNCs. Irradiated recipient mice were transplanted
with 4 3 105 BM MNCs from Foxo3a+/+ or Foxo3a/ mice plus 4 3 105 competitor cells in a competitive assay as described in the Experimental
Procedures. Data shown are the mean percentage ± SD of donor-derived cells in the peripheral blood at the indicated time points after transplantation
(n = 3).
(C) Defective repopulation of KSL cells derived from Foxo3a/ BM cells after transplantation. BM cells from the recipient mice in (B) were analyzed for
the frequency of KSL cells in donor-derived (CD45.2+) MNCs at 16 weeks posttransplantation. Representative data for the frequency of KSL popu-
lation are shown. (Insets) Mean percentage ± SD of KSL cells in donor-derived MNCs (*p < 0.01, n = 3).
(D) Defective repopulation capacity of Foxo3a/ BM MNCs during serial transplantation. BM MNCs from the recipient mice were serially transplanted
into recipient mice as described in the Experimental Procedures. The repopulating capacity of Foxo3a+/+ and Foxo3a/ BM donor cells was deter-
mined at 16 weeks posttransplant for the first, second, and third BMTs. Data shown are the mean ratio ± SD of donor-derived cells in a competitive
assay (*p < 0.01, n = 4).posttransplantation, flow cytometric analysis of the pe-
ripheral blood of the transplanted recipients revealed
that Foxo3a+/+ and Foxo3a/ BM MNCs were equally ca-
pable of hematopoietic reconstitution (Figure 2B). We then
analyzed the chimerism of donor-derived cells in the BM
and found wild-type numbers of Foxo3a/-derived B
cells, myeloid cells, and erythroid cells (data not shown)
but greatly reduced numbers of KSL cells (Figure 2C).
These results indicate that Foxo3a is not crucial for HSC
differentiation but plays a critical role in HSC self-renewal.
To examine the impact of the reduced KSL population
derived from Foxo3a/ BM cells on hematopoiesis, we
carried out second competitive transplantation. At 16
weeks post first BMT, 13 106 BM MNCs from these recip-
ients, including donor-derived BM cells (CD45.2), compet-
itor-derived BM cells, and residual recipient BM cells
(CD45.1), were transplanted into a second set of recipient
mice (CD45.1) (second BMT). At 16 weeks post second
BMT, fewer hematopoietic cells in the second recipients104 Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc.were derived from Foxo3a/ BM MNCs compared to
Foxo3a+/+ BM MNCs (Figure 2D), indicating that the
reconstituted HSC pool derived from Foxo3a/ BM cells
after the first BMT was decreased. At 16 weeks post third
BMT, the proportion of Foxo3a+/+ BM MNC-derived cells
was reduced compared to that at 16 weeks post second
BMT. This deficit arises presumably because the repopu-
lating capacity of the donor and competitor cells is de-
creased by repeated BMT, whereas residual recipient
BM cells continue to accumulate. Nevertheless, examina-
tion of BM cells after a third transplantation revealed a fur-
ther reduction in the reconstitution capacity of Foxo3a/
BM cells compared to Foxo3a+/+ BM cells. These data
confirm that Foxo3a is essential for the self-renewal
capacity of HSCs.
HSC-Specific Dysfunction in Foxo3a/ Mice
We next set out to characterize the cell population most
dependent on Foxo3a. As previously reported (Yamazaki
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(A) Nuclear localization of Foxo3a in HSCs. (Upper panel) Freshly isolated CD34 or CD34+KSL cells from Foxo3a+/+ BM were stained with DAPI (blue)
and anti-Foxo3a antibody (red). (Lower panel) The fluorescence intensity of anti-Foxo3a staining at points in each region was plotted as the number of
pixels (z axis) relative to the position of these points along the x-y axis.
(B) Defective clonogenic capacity of Foxo3a/ CD34KSL cells in vitro. CD34+ and CD34KSL cells from Foxo3a+/+ or Foxo3a/ mice were cultured
in the presence of cytokines in methylcellulose medium for 7 days. Data shown are the mean number of colonies or clusters formed per 100 cells ± SD
(**p < 0.05, n = 3).
(C) Defective long-term reconstitution capacity of Foxo3a/ KSL cells in vivo. Irradiated recipient mice were transplanted with 23 103 KSL cells from
Foxo3a+/+ or Foxo3a/ mice plus 43 105 competitor cells in a competitive assay. Data shown are the mean percentage ± SD of donor-derived cells
in the peripheral blood at indicated time after transplantation (*P < 0.01, **P < 0.05, n = 3).
(D) Comparable short-term hematopoietic reconstitution capacity of Foxo3a+/+ and Foxo3a/ CD34+KSL cells. Irradiated recipient mice were trans-
planted with 3.3 3 103 CD34+KSL cells from Foxo3a+/+ or Foxo3a/ mice plus 43 105 competitor cells in a competitive assay. Data shown are the
mean percentage ± SD of donor-derived cells in the peripheral blood at 4 weeks after transplantation (n = 3).
(E) Defective long-term reconstitution capacity of Foxo3a/ CD34KSL cells. Recipient mice were transplanted with 200 CD34KSL cells from
Foxo3a+/+ or Foxo3a/ mice plus 43 105 competitor cells in competitive assays, and long-term reconstitution capacity was assessed. Data shown
are the mean percentage ± SD of donor-derived cells at 16 weeks posttransplantation (**p < 0.05, n = 4).et al., 2006), Foxo3a protein is present in the nucleus of
freshly isolated Foxo3a+/+ CD34KSL cells (HSCs) but ap-
pears in the cytoplasm of freshly isolated Foxo3a+/+
CD34+KSL cells (progenitors) (Figure 3A). When we evalu-
ated the in vitro clonogenic capacity of purified Foxo3a+/+
CD34+KSL and CD34KSL cells, we found that
CD34+KSL cells generated much larger colonies than
did CD34KSL cells by day 7. However, the clusters (small
colonies) derived from CD34KSL cells caught up in size
by day 14, confirming that CD34KSL cells are less ma-
ture than CD34+KSL cells. When we carried out the
same clonogenic assay using Foxo3a/ CD34+KSL and
CD34KSL cells, the numbers of colonies generated byFoxo3a+/+ and Foxo3a/ CD34+KSL cells were equiva-
lent (Figure 3B). In contrast, the loss of Foxo3a resulted
in a mild but significant reduction in the number of clusters
derived from CD34KSL cells. Despite this decrease in
number, the differentiation potential of the clusters de-
rived from CD34KSL cells was not obviously affected
by Foxo3a deficiency (Figure S3). These data indicate
that loss of Foxo3a results in a defect in in vitro clonogenic
capacity that is specific to HSCs.
To evaluate HSC function in vivo, we evaluated the
repopulating capacity of purified KSL cells using the
competitive reconstitution assay. At 4 weeks post-
transplantation, the repopulating capacity of Foxo3a/Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc. 105
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suggesting that loss of Foxo3a does not affect progenitor
function (Figure 3C). However, at later time points in the
experiment, the repopulating capacity of Foxo3a/ KSL
cells was lower than that of Foxo3a+/+ KSL cells. These
data suggested that Foxo3a deficiency might cause an
in vivo defect that impaired the function of HSCs but not
that of progenitors. To confirm the effect of Foxo3a defi-
ciency on HSC function in vivo, we examined the short-
term reconstitution capacity of CD34+KSL progenitors,
as well as the long-term reconstitution capacity of
CD34KSL HSCs, in competitive transplantation assays.
Foxo3a/ CD34+KSL cells supported normal reconstitu-
tion of hematopoiesis in short-term (4 weeks) experiments
(Figure 3D), consistent with our earlier finding that Foxo3a
is not involved in CD34+KSL function. In contrast, the loss
of Foxo3a in CD34KSL HSCs led to a significant defect
in reconstitution by 16 weeks posttransplantation (Fig-
ure 3E), indicating that Foxo3a is essential for the long-
term repopulating capacity of HSCs. Since anemia was
not observed in recipient mice (data not shown), the de-
fect in the erythroid lineage did not affect the repopulating
capacity of Foxo3a/ HSCs. Thus, Foxo3a/ mice have
a profound defect in HSC function, but not in progenitor
function.
Failure of Quiescence Maintenance
in Foxo3a/ HSCs
HSCs are normally maintained in an undifferentiated qui-
escent state (G0 phase), and this quiescence protects
HSCs against losing self-renewal capacity. To evaluate
the quiescence status of HSCs in Foxo3a/ mice, we first
examined the cell-cycle status of KSL cells using BrdU (5-
bromodeoxyuridine) incorporation. No differences were
found between Foxo3a+/ and Foxo3a/ mice in the per-
centage of KSL cells that had undergone cell division over
a 2 hr period (Figure 4A). Obvious apoptosis was not ob-
served in either Foxo3a+/+ or Foxo3a/ KSL cells (Fig-
ure S4). To directly evaluate HSC quiescence in Foxo3a/
mice, we stained CD34KSL cells from Foxo3a+/+ and
Foxo3a/ mice with Pyronin Y, an agent that specifically
and quantitatively stains double-stranded RNA and accu-
rately reflects the G0 phase (Huttmann et al., 2001). Con-
sistent with previous work (Yamazaki et al., 2006), we
found that most Foxo3a+/+ CD34KSL cells stained nega-
tively for Pyronin Y, indicating normal HSC quiescence.
However, a sizable Pyronin Y+ population was detected
among Foxo3a/ CD34KSL cells (Figure 4B). To inves-
tigate whether Foxo3a/ CD34KSL cells were cycling
in vivo, BrdU was administered to mice orally for 7 days.
Whereas Foxo3a+/+ CD34KSL cells showed minimal
BrdU incorporation, almost 60% of Foxo3a/ cells were
BrdU+ (Figure 4C). These results indicate that Foxo3a de-
ficiency drives HSCs to abandon the G0 phase and enter
the cell cycle. With respect to the CD34+KSL population,
70%–80% of these cells were BrdU+ in both Foxo3a+/+
and Foxo3a/ mice. The defect in HSC quiescence in
the absence of Foxo3a was further supported by the
finding of decreased levels of the negative cell-cycle106 Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc.regulators p27 and p57 in Foxo3a/ CD34KSL cells
(Figure 4D).
Cheng et al. have reported that loss of p21 leads to a fail-
ure in the maintenance of HSC quiescence. In this case,
when the mutant animals were exposed to the cell-
cycle-specific myelotoxic drug 5-FU as an exogenous
stress, they died prematurely due to hematopoietic cell
depletion (Cheng et al., 2000). These observations promp-
ted us to investigate the sensitivity of Foxo3a/ mice and
their hematopoietic cells to weekly 5-FU treatments. Al-
though some 5-FU-treated Foxo3a+/+ mice died at 2
weeks after the initial injection, fully 60% of them survived
until at least 4 weeks postinjection (Figure 4E). In contrast,
all Foxo3a/ mice were dead within 4 weeks after the first
injection, showing that Foxo3a is required for normal HSC
resistance to 5-FU. To exclude the possibility that the
death of the mice was due to the toxic effects of 5-FU
on other tissues, we repopulated the hematopoietic sys-
tem of lethally irradiated recipients with either Foxo3a+/+
or Foxo3a/ BM cells. Four months after transplantation,
we challenged the reconstituted mice with weekly 5-FU
treatments. A similar increase in mortality was observed
in mice transplanted with Foxo3a/ BM cells as com-
pared to those bearing Foxo3a+/+ BM cells (Figure 4F).
Thus, 5-FU-treated Foxo3a/ mice die prematurely due
to effects on the hematopoietic system and not because
of the sensitivity of other tissues to the antimetabolite
treatment. Foxo3a therefore protects hematopoietic cells
from destruction by cell-cycle-dependent myelotoxic
agents, and a loss of Foxo3a leads to hematopoietic cell
depletion and premature death of the animal. Taken to-
gether, our data demonstrate that Foxo3a plays a pivotal
role in the maintenance of HSC quiescence and suggest
that Foxo3a functions to protect HSCs against exogenous
stress.
Impaired HSC Function by p38MAPK Activation
in Foxo3a/ Mice
We have previously reported that p38MAPK activation in-
duced by ROS elevation promotes exhaustion of HSCs
during serial BM transplantation (Ito et al., 2006). We
therefore evaluated ROS levels and the activation status
of p38MAPK in HSCs of Foxo3a+/+ and Foxo3a/ mice.
ROS was indeed increased in Foxo3a/ KSL cells com-
pared to Foxo3a+/+ KSL cells (Figure 5A). Moreover, the
expression levels of SOD2 and catalase, two Foxo target
genes involved in ROS detoxification (Essers et al.,
2004; Kops et al., 2002; Nemoto and Finkel, 2002), were
significantly downregulated in Foxo3a/ CD34KSL cells
(Figure 5B). When p38MAPK phosphorylation was exam-
ined in hematopoietic cell subsets of Foxo3a+/+ and
Foxo3a/ mice, fewer than 10% of CD34KSL cells in
Foxo3a+/+ mice showed p38MAPK phosphorylation (Fig-
ures 5C and 5D). In contrast, p38MAPK was phosphory-
lated in approximately 30% of Foxo3a/ CD34KSL
cells. Interestingly, we found that more CD34KSL cells
than CD34+KSL cells showed p38MAPK phosphorylation
in Foxo3a/ BM but that neither Lin nor Lin+ cells had
significant levels of phosphorylated p38MAPK. This
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(A) Equivalent cell-cycle status of Foxo3a+/ and Foxo3a/ KSL cells. Two hours after i.p. injection of BrdU into Foxo3a+/ or Foxo3a/ mice, KSL
cells were isolated and stained with anti-BrdU antibody and 7AAD to evaluate cell-cycle status. (Insets) Percentages of cells in G1, S, or G2/M phase.
Results shown are one cell-cycle analysis representative of three independent experiments.
(B) Reduced frequency of quiescent cells in the CD34KSL population. CD34KSL cells of Foxo3a+/+ or Foxo3a/ mice were stained with Pyronin Y
and analyzed by flow cytometry. (Left and middle panels) Results of one trial representative of four independent experiments. (Right panel) The mean
percentage ± SD of Pyronin Y cells in the CD34KSL population (**p < 0.05, n = 4).
(C) Increased BrdU incorporation in Foxo3a/ CD34KSL cells. BrdU was administered orally to Foxo3a+/+ and Foxo3a/ mice for 7 days, and BrdU
incorporation in CD34+ or CD34KSL cells was evaluated by using anti-BrdU antibody. Data shown are the mean percentage ± SD of BrdU+ cells in
the CD34KSL (left panel) or CD34+KSL (right panel) populations (*p < 0.01, n = 3).
(D) Decreased p27 and p57 expression in Foxo3a/ CD34KSL cells. The relative mRNA expression levels of p21, p27, and p57 in CD34KSL cells
from Foxo3a+/+ or Foxo3a/ mice were evaluated by quantitative real-time RT-PCR and normalized to b-actin expression. Data shown are the mean
ratio ± SD of transcript levels over b-actin (*p < 0.01, n = 3).
(E and F) Increased sensitivity to myelotoxic stress. (E) Foxo3a+/+ and Foxo3a/ mice (n = 10) were i.p. injected with 5-FU (150 mg/kg) weekly, and
survival was monitored daily. Data shown are the survival rates expressed as a percentage. Results were analyzed with a log-rank nonparametric test.
(F) Irradiated recipient mice (n = 6) transplanted with Foxo3a+/+ or Foxo3a/ BM cells were subjected to the same 5-FU protocol. Survival rate was
determined as for (E).increased phosphorylation of p38MAPK in Foxo3a/
CD34KSL cells could be significantly inhibited by prior
administration to the mice of the antioxidant N-acetyl-L-
cysteine (NAC), although it was a partial effect (Figure 5E).
Finally, we evaluated the effect of a p38MAPK inhibitor
(SB203580) on the ability of Foxo3a/ cells to generate
colonies after 6 weeks of culture (a reflection of HSC func-
tion). We found that the colony-forming capacity of
Foxo3a/ KSL cells subjected to long-term culture could
be restored by treatment with 10 mM SB203580 (Fig-
ure 5F). In the absence of this p38MAPK inhibitor, thenumber of colonies generated from Foxo3a/ cells was
reduced to the levels previously shown in Figure 2A, indi-
cating that p38MAPK activation impairs HSC function.
Decreased HSC Pool in Aged Foxo3a/ Mice
All the data presented above were obtained from
studies of young adult (8- to 12-week-old) Foxo3a+/+ and
Foxo3a/ mice. Despite the defective HSC self-renewal
capacity in Foxo3a/ mice, the frequency of CD34KSL
cells in these mutants was similar to that in Foxo3a+/+
mice (Figure S5). Thus, a loss of Foxo3a does not influenceCell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc. 107
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(A) Elevation of ROS. Intracellular H2O2 concentrations of Foxo3a
+/+ and Foxo3a/ KSL cells were determined by the DCFDA assay. Data shown are
representative of three independent experiments.
(B) Reduced SOD2 and catalase expressions. The mRNA expression levels of SOD2 and catalase were determined in Foxo3a+/+ and Foxo3a/
CD34KSL cells using quantitative real time RT-PCR and normalized to b-actin expression. Data shown are the mean ratio ± SD of transcript levels
over b-actin (*p < 0.01, n = 3).
(C and D) Increased p38MAPK phosphorylation. CD34 and CD34+KSL cells from Foxo3a+/+ and Foxo3a/ mice were stained with anti-phospho-
p38MAPK mAb. DAPI staining (blue) was used to detect nuclei. Representative data are shown in (C). Arrowheads, phospho-p38MAPK+ cells. (Insets)
Higher magnification of representative phospho-p38MAPK+ cells. Data shown in (D) are the mean percentage ± SD of phospho-p38MAPK+ cells in
the CD34, CD34+, Lin, and Lin+ fractions of BM cells from Foxo3a+/+ and Foxo3a/ mice (*p < 0.01, n = 5).
(E) Inhibition of p38MAPK phosphorylation by NAC treatment. Foxo3a+/+ and Foxo3a/ mice were administered NAC in vivo and p38MAPK activa-
tion in Foxo3a+/+ and Foxo3a/ CD34KSL cells was determined as for (D). Data shown are the mean percentage ± SD of phospho-p38 MAPK+ cells
in the CD34KSL cell population (*p < 0.01, n = 3).
(F) Restored colony-forming capacity after long-term culture with a p38MAPK inhibitor. Foxo3a+/+ and Foxo3a/ mice KSL cells were cultured on
OP9 stromal cells with or without 10 mM SB203580 for 6 weeks, and colony formation assays were performed as for Figure 2A. Data shown are
the mean number ± SD of colonies formed (*p < 0.01, n = 3).HSC numbers in vivo in young adult mice. However, it was
quite possible that the defect in self-renewal capacity
could lead to a shortened HSC life span in vivo that would
become evident as the mice aged. We therefore evaluated
hematopoiesis in aged Foxo3a+/+ and Foxo3a/ mice
and observed that the peripheral blood of aged
Foxo3a/ mice did not show any signs of progressive he-
matopoietic failure (Table S1). However, there was a re-
duction in the frequency of CD34KSL cells in aged
Foxo3a/ mice as compared to the littermate controls
(Figures 6A and 6B and Figure S6). As previously reported
(Rossi et al., 2005; Sudo et al., 2000), the frequency of
CD34KSL population in aged Foxo3a+/+ mice was higher
than that in young mice. Our aged Foxo3a/ mice did not108 Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc.show the expansion of CD34KSL cells seen in aged wild-
type mice. The frequency of the CD34+KSL progenitor
population was reduced in some, but not all, aged
Foxo3a/ mice. These results indicate that the loss of
Foxo3a had its dominant effect on the HSC population in
aged animals. To investigate the effect of aging on HSC
function, we evaluated repopulating capacity of aged
Foxo3a/ HSCs. When we carried out the clonogenic as-
say using KSL cells from aged Foxo3a/ mice, we found
reduced colony formation activity in aged Foxo3a/ mice
(Figure 6C), in contrast to the results obtained for young
Foxo3a/ mice (Figure 1D). Similarly, when we carried
out long-term cultivation of KSL cells from aged
Foxo3a/ mice on a layer of OP9 stromal cells, the
Cell Stem Cell
Essential Role of Foxo3a in Self-Renewal of HSCsFigure 6. Decreased HSC Pool in Aged Foxo3a/ Mice
(A) CD34KSL (upper panels) and CD34+KSL (lower panels) cells from 80-week-old Foxo3a+/+ or Foxo3a/ mice were analyzed by flow cytometry.
(Insets) Percentage of CD34 or CD34+KSL cells in total BM MNCs.
(B) Mean frequency ± SD of CD34KSL (upper panel) and CD34+KSL (lower panel) cells in aged Foxo3a/ mice compared to littermate Foxo3a+/+
mice (56–108 weeks old) (*p < 0.01, n = 6).
(C) Reduced in vitro colony formation capacity. KSL cells from aged Foxo3a+/+ or Foxo3a/ mice were cultured with cytokines in methylcellulose
medium for 7 days. Data shown are the mean number ± SD of colonies formed (n = 3).
(D) Decreased colony formation after long-term culture. KSL cells (23 103) from aged Foxo3a+/+ and Foxo3a/ mice were cultured on OP9 stromal
cells for 2 weeks and tested for colony formation. Data shown are the mean number ± SD of colonies formed (*p < 0.01, n = 3).
(E) Defective long-term reconstitution capacity of BM MNCs from aged Foxo3a/ mice. Irradiated recipient mice were transplanted with 1 3 106
Foxo3a+/+ or Foxo3a/ BM MNCs plus 13 106 competitor cells in a competitive assay. Data shown are the mean percentage ± SD of donor-derived
cells in the peripheral blood at 12 weeks after transplantation (*p < 0.01, n = 3).number of colony-forming cells arising after 2 weeks of
culture was dramatically decreased (Figure 6D) in a man-
ner not observed for KSL cells from young Foxo3a/ mice
(Figure 2A). Furthermore, the long-term repopulating
capacity of BM MNCs from aged Foxo3a/ mice was sig-
nificantly reduced compared to that of BM MNCs from
aged Foxo3a+/+ mice (Figure 6E), in contrast to the results
obtained for young Foxo3a+/+ and Foxo3a/ mice (Fig-
ure 2B). These data demonstrate that the defect in repo-
pulation capacity of aged Foxo3a/ HSCs was more se-
vere than that of young Foxo3a/ HSCs. We therefore
conclude that the loss of Foxo3a leads to a defect in the
self-renewal capacity of HSCs that impairs the main-
tenance of in vivo HSC pool during aging.DISCUSSION
The self-renewal of postnatal HSCs is closely coupled to
their slow cell cycling or quiescence, and the maintenance
of HSC quiescence is thought to be a requisite for sustain-
ing a self-renewing HSC compartment. Here we show that
Foxo3a/ HSCs can neither maintain quiescence nor
support long-term reconstitution of hematopoiesis. The
mutant HSCs exhibit increased phosphorylation of
p38MAPK, show a heightened sensitivity to cell-cycle-
specific myelotoxic injury, and lose self-renewal capacity
during aging.
In quiescent wild-type HSCs, Akt is not activated, and
Foxo proteins are localized in the nucleus (YamazakiCell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc. 109
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in vitro, Akt becomes activated and induces the export of
Foxo proteins from the nucleus to the cytoplasm. In con-
junction with this export, the HSCs lose their repopulating
capacity. Attenuation of cytokine signaling by lipid raft
inhibitors maintains both HSC quiescence and nuclear lo-
calization of Foxo proteins (Yamazaki et al., 2006). These
findings suggest that the fine tuning of cytokine signals
within a niche can influence Foxo localization, which in
turn governs HSC quiescence. It has been reported that
FOXO regulates the expression of p21 and p27 (Dijkers
et al., 2000a; Medema et al., 2000; Seoane et al., 2004).
In this study, we observed decreased expression of p27
and p57, but not p21, in Foxo3a/ HSCs. We therefore
speculate that, in our mutant mice, the loss of Foxo3a
may have directly reduced the expression of multiple neg-
ative regulators of the cell cycle, resulting in the observed
defect in the maintenance of HSC quiescence. On the
other hand, Foxo3a/ HSCs showed elevated ROS as
well as reduced expression of SOD2 and catalase, two
Foxo targets that are involved in ROS detoxification (Ess-
ers et al., 2004; Kops et al., 2002; Nemoto and Finkel,
2002). Because ROS elevation disrupts the maintenance
of HSC quiescence, it may be that Foxo3a deficiency
causes HSC cell cycle abnormalities via ROS dysregula-
tion. We previously reported that p38MAPK activation
induced by oxidative stress leads to a defect in HSC self-
renewal capacity (Ito et al., 2006). Consistent with this find-
ing, our present study showed that Foxo3a contributes
to maintain HSC capacity mediated by repression of
p38MAPK activation. However, ROS-independent path-
way might induce p38MAPK activation inFoxo3a/ HSCs, be-
cause NAC treatment partially restored p38MAPK status.
Our knowledge of the physiological intrinsic cues regu-
lating HSC maintenance and expansion remains limited.
The tumor suppressor Pten (phosphatase and tensin ho-
molog) has been found to regulate HSC maintenance
through restriction of HSC proliferation (Yilmaz et al.,
2006; Zhang et al., 2006). The finding is especially interest-
ing to us, as PTEN acts upstream of FOXO. Pten defi-
ciency leads to activation of PI3K that results in Akt activa-
tion and consequently Foxo inactivation. This relationship
could theoretically underlie the similarities in the pheno-
types of Pten-deficient and Foxo3a/ HSCs with respect
to cell cycle regulation and repopulating capacity,
although our Foxo3a/ mice do not develop leukemia.
Yilmaz et al. reported that the mTOR inhibitor rapamycin
not only depleted leukemia-initiating cells in Pten-defi-
cient mice but also restored normal HSC function, indicat-
ing that mTOR activation causes the loss of HSC function
in these animals (Yilmaz et al., 2006). Since it has recently
been reported that rapamycin can indirectly inhibit Akt ac-
tivation (Sarbassov et al., 2006), the possibility thus exists
that rapamycin treatment restores HSC function by pro-
moting Foxo activation. It will be interesting to determine
whether Foxo3a acts downstream of Pten to regulate
HSC function.
Despite the fundamental importance of HSCs and
Foxo3a’s role in their maintenance, our Foxo3a/ mice110 Cell Stem Cell 1, 101–112, July 2007 ª2007 Elsevier Inc.did not show any obvious abnormalities in embryogene-
sis, aging, or function of the hematopoietic system in the
absence of exogenous stress. The extreme subtlety of
the phenotypes of Foxo3a/ mice is likely due to com-
pensation by other Foxo family members. While this man-
uscript was under review, phenotypes by conditional
deletions of Foxo1, -3a, and -4 genes were reported
(Paik et al., 2007; Tothova et al., 2007). Tothova et al. dem-
onstrated that deletions of triple genes lead to marked
decrease of KSL population with increased apoptosis
and cell cycling caused by an elevation of ROS. Deficiency
of Foxo3a single gene did not show any phenotypes in
KSL population, consistent with our data. Since pheno-
types of aged Foxo3a/ mice were more severe than
those of young mice in our study, the compensatory
effects by other family members may be attenuated during
aging.
Stem cells and progenitors are now known to exist in
a variety of tissues. Tissue-specific stem cells continu-
ously give rise to mature cells throughout the life of an
animal and maintain the homeostasis of a particular tis-
sue. Our study shows that Foxo3a is essential for the
maintenance of the self-renewal capacity of HSCs in vivo.
It has been reported that Foxo family members reg-
ulate the differentiation potential of progenitors (Bakker
et al., 2004; Hribal et al., 2003). Since the aging of an or-
ganism may be driven in part by a gradual depletion of
the functional capacity of tissue-specific stem cells,
Foxo3a might be involved in controlling physiological ag-
ing mediated by regulating stem cell capacity in a variety
of tissues. Furthermore, manipulation of Foxo3a may rep-
resent a novel approach to regenerative medicine. It may
be possible in the future to establish a culture system in
which Foxo3a activation is modified such that HSCs can
expand while maintaining their repopulating capacity. If
such a modification of FOXO function can be generalized
to stem cells of other tissues, this approach could be
useful for enhancing or sustaining tissue regenerative
capacity in vivo.
EXPERIMENTAL PROCEDURES
Mice and Blood Cell Counts
Foxo3a/ mice were generated as described in the Supplemental
Experimental Procedures and in Figure S1. Heterozygous Foxo3a+/
mice were subsequently intercrossed to generate Foxo3a/ mice in
C57BL/6 (F4). Littermates were used as controls in all experiments.
C57BL/6 CD45.1 congenic mice (B6-CD45.1) were purchased from
Sankyo-Lab Service (Tsukuba, Japan). Animal care in our laboratory
was in accordance with the guidelines for animal and recombinant
DNA experiments of the National Institute for Longevity Sciences,
Keio University and Kanazawa University. NAC was administrated
orally (40 mM in drinking water) for 4 weeks. For analysis of blood
counts, peripheral blood from the postorbital vein was collected in
a heparinized microtube (Drummond Scientific) and analyzed on a
CellTac (NIHON KOHDEN).
Flow Cytometry
Monoclonal antibodies (mAbs) recognizing the following markers were
used for flow cytometric analyses and cell sorting (FACS Vantage or
FACS Aria, BD Bioscience): c-Kit (2B8), Sca-1 (E13-161.7), CD4
Cell Stem Cell
Essential Role of Foxo3a in Self-Renewal of HSCs(L3T4), CD8 (53-6.7), B220 (RA3-6B2), TER-119 (Ly-76), Gr-1 (RB6-
8C5), CD34 (RAM34), CD71 (R17217), CD45.1(A20), CD45.2(104),
and anti-Mac-1 (M1/70). All mAbs were purchased from BD Biosci-
ences. A mixture of mAbs recognizing CD4, CD8, B220, TER-119,
Mac-1, or Gr-1 was used to identify Lin+ cells.
Colony-Forming Assays
For long-term cultures, 2 3 103 KSL cells were cocultured with OP9
stromal cells as previously described (Ito et al., 2004). After 2–6 weeks’
culture, cells were harvested and used for hematopoietic colony-form-
ing assays. For some experiments, the p38MAPK inhibitor SB203580
(Calbiochem) was added at 10 mM to long-term cultures. Methylcellu-
lose colony-forming assays were performed with 20 ng/ml SCF (Pepro
Tech EC Ltd.), 20 ng/ml interleukin-3 (PeproTech EC Ltd.), 2 U/ml Epo
(Chugai Pharmaceutical Co., Ltd.), and 20 ng/ml G-CSF (Kirin Brewery
Co., Ltd.) as previously described (Arai et al., 2004). For the day 12 CFU
spleen (CFU-S12) assay, 53 104 BM MNCs were injected into lethally
irradiated mice. Colonies growing in the spleen were fixed and counted
12 days after injection as previously described (Ito et al., 2004).
Competitive Reconstitution Assay
Lethally irradiated C57BL/6-CD45.1 congenic mice were reconstituted
with BM MNCs, KSL cells, CD34+KSL cells, or CD34KSL cells from
Foxo3a+/+ or Foxo3a/ mice (CD45.2), in competition with BM
MNCs from C57BL/6-CD45.1 mice. Reconstitution of donor-derived
cells (CD45.2) was monitored by staining blood cells with mAbs
against CD45.2, CD45.1, CD3, B220, Mac-1, and Gr-1. For the serial
transplantation analysis, BM cells (1 3 106) were obtained from recip-
ient mice at 16 weeks posttransplantation (first BMT) and transplanted
into a second set of lethally irradiated mice (second BMT). Subsequent
transplantations were performed in the same manner.
5-FU Treatment
5-FU (Kyowa Hakko) was administered to mice intraperitoneally (i.p.) at
a dose of 150 mg/kg once per week for 3 weeks, and the survival of
individual mice was monitored daily.
Intracellular ROS Assay
The cells were incubated with 300 nM CM-H2-DCFDA (Invitrogen) at
37C for 5 min followed by analysis of fluorescence by flow cytometry.
Cell-Cycle Analyses
Analysis of the G0 phase by Pyronin Y staining was performed as pre-
viously described (Yamazaki et al., 2006). To determine KSL cell-cycle
status by BrdU incorporation in vivo, BrdU (100 mg/kg; Sigma) was
injected i.p. into Foxo3a+/or Foxo3a/ mice. At 2 hr postinjection,
KSL cells were collected from BM, fixed, and stained with 7AAD and
anti-BrdU antibody (BD Biosciences) as previously described (van
Pelt et al., 2005). For analysis of in vivo BrdU incorporation in
CD34KSL cells, BrdU was administered to mice orally for 7 days
(1 mg/ml in sterile deionized water), and CD34KSL cells were col-
lected by flow cytometry. The isolated CD34KSL cells were fixed
and treated with anti-BrdU antibody as above.
Apoptosis
Lin cells were collected from total BM cells using the MACS cell sep-
arator system (Miltenyi Biotec). Lin cells were stained with propidium
iodide (PI) and Annexin V (R & D Systems) to detect apoptotic cells.
Immunocytochemistry
Immunocytochemistry of CD34 and CD34+KSL cells was performed
as previously described (Yamazaki et al., 2006). Briefly, cells were di-
rectly sorted onto a glass slide, fixed with 4% paraformaldehyde (PFA),
and stained with anti-Foxo3a mAb (Upstate Cell Signaling Solutions) or
anti-phospho-p38MAPK mAb (Cell Signaling Technology). Nuclei were
identified by staining with DAPI or TOTO-3 (Invitrogen). Subcellular
localizations were determined by using confocal microscopy.The fluorescence intensity of each region was analyzed by National
Institutes of Health Image.
RT-PCR
cDNAs were reverse-transcribed from total RNA prepared from
CD34KSL cells. To quantify transcripts, cDNA was subjected to
real-time PCR using SYBR Premix Ex Taq (Takara Bio) in Real-Time
PCR System Mx3000P (Stratagene). Amplification of b-actin was
used for sample normalization. Primer sequences are as follow: p21,
50-CCGCTGGAGGGCAACTTCGT-30, 50-TTTCGGCCCTGAGATGTT
CC-30; p27/Kip1, 50-TCTCAGGCAAACTCTGAGGAC-30, 50-TTCGGAG
CTGTTTACGTCTGG-30; p57/Kip2, 50-TGATGAGCTGGGAACTGAG
CC-30, 50-ACGTCGTTCGACGCCTTGTTC-30; SOD2, 50-CCCAGACCT
GCCTTACGACTAT-30, 50-TCTCCCAGTTGATTACATTCCA-30; Cata-
lse, 50-GGGAACCCAATAGGAGATAAACTT-30, 50-GGTCACTGAACAA
GAAAGAAACCT-30; and b-actin, 50-AGGTCATCACTATTGGCAAC
GA-30, 50-CACTTCATGATGGAATTGAATGTAGTT-30.
Statistical Analyses
P values were calculated by using the unpaired Student’s t test except
for the 5-FU experiments. Survival rates following 5-FU treatment were
analyzed with a log-rank nonparametric test.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at
http://www.cellstemcell.com/content/full/1/1/101/DC1/.
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